SEC Company Response from Apyx Medical (APYX) — Dec 12, 2025
Apyx Medical Corp
Date: Dec. 12, 2025 · CIK: 0000719135 · Accession: 0001493152-25-027478
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-291865
Letter
APYX MEDICAL CORPORATION
Ulmerton Road
Clearwater, Florida 33760
December 12, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
F. St., N.E.
Washington, D.C. 20549
Re: Apyx Medical Corporation Registration Statement on Form S-3 File No. 333-291865 Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Apyx Medical Corporation hereby requests the acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-291865) so that it will become effective on Tuesday, December 16, 2025, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable.
Please call Adam Silvers or Dominick Ragno of Ruskin Moscou Faltischek P.C. at (516) 663-6600 to provide notice of the effectiveness of the Registration Statement.
Very
truly yours,
Apyx
Medical Corporation
Show Raw Text
CORRESP 1 filename1.htm APYX MEDICAL CORPORATION 5115 Ulmerton Road Clearwater, Florida 33760 December 12, 2025 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. St., N.E. Washington, D.C. 20549 Re: Apyx Medical Corporation Registration Statement on Form S-3 File No. 333-291865 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Apyx Medical Corporation hereby requests the acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-291865) so that it will become effective on Tuesday, December 16, 2025, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable. Please call Adam Silvers or Dominick Ragno of Ruskin Moscou Faltischek P.C. at (516) 663-6600 to provide notice of the effectiveness of the Registration Statement. Very truly yours, Apyx Medical Corporation By: /s/ Matt Hill Matt Hill, Chief Financial Officer cc: Adam Silvers, Ruskin Moscou Faltischek P.C. Dominick Ragno, Ruskin Moscou Faltischek P.C.